Authors
Loading...
Experimental study shows combined sorafenib and insulin significantly reduces VEGF and hif-1α in diabetic retinopathy, indicating potential treatment benefits.
Usenko et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: